Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
JAMA Network Open|October 24, 2022
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal CancerChad Moretz, Stacey DaCosta Byfield, Kathryn E Hatchell, et al.
The Journal of Urology|June 11, 2024
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective StudyMouneeb M Choudry, Adri M Durant, Victoria S Edmonds, et al.
Urologic Oncology|October 31, 2024
Germline genetic testing for prostate cancer: Ordering trends in the era of expanded hereditary cancer screening recommendationsJacob L Roberts, Luke Luchen Wang, Brent Rose, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2025
Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility GenesSarah M Nielsen, Emily M Russell, Rachel E Ellsworth, et al.
British Journal of Cancer|December 24, 2021
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancerElio Adib, Talal El Zarif, Amin H Nassar, et al.
Molecular Genetics & Genomic Medicine|December 20, 2022
Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian studyHikmat Abdel-Razeq, Khansa Al-Azzam, Shatha Elemian, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2022
Germline alterations among Hispanic men with prostate cancerElizabeth Pan, Justin Shaya, Lisa Madlensky, et al.
Cancer Medicine|August 14, 2019
Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort studyAllison H West, Hayley Knollman, James Dugan, et al.
JCO Global Oncology|July 22, 2022
Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional StudyCarlos Andrés Ossa Gomez, Maria Isabel Achatz, Mabel Hurtado, et al.
JCO Precision Oncology|July 12, 2021
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline VariantsAnya Mezina, Neil Philips, Zoe Bogus, et al.
Pageof 6